Establishment of highly invasive pancreatic cancer cell lines and the expression of IL-32

被引:13
作者
Takagi, Kohji [1 ]
Imura, Johji [1 ]
Shimomura, Akiko [1 ]
Noguchi, Akira [1 ]
Minamisaka, Takashi [1 ]
Tanaka, Shinichi [1 ]
Nishida, Takeshi [1 ]
Hatta, Hideki [1 ]
Nakajima, Takahiko [1 ]
机构
[1] Univ Toyama, Acad Assembly, Fac Med, Dept Diagnost Pathol, 2630 Sugitani, Toyama, Toyama 9300194, Japan
基金
日本学术振兴会;
关键词
pancreatic cancer cell; invasion; comprehensive genomic analysis; cell culture; interleukin-32; INTERLEUKIN-32; PROGRESSION; GENE;
D O I
10.3892/ol.2020.11825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Compared to tumors of other organs, pancreatic cancer is highly aggressive; with one of its biological features being that, despite a prominent fibrotic stroma, there is remarkable infiltration of tumor cells. This characteristic is considered to be the main reason for the poor prognosis of patients with pancreatic cancer. Therefore, in order to elucidate the factors that contribute to this high invasiveness, a selective invasion method was used to establish four highly invasive subclones from six human pancreatic cancer cell lines. The results demonstrated that two cell lines did not exhibit enhanced invasiveness. Microarray analysis revealed that, in the highly invasive cell lines, several genes were expressed at high levels, compared with the original cell lines. These highly expressed genes were recognized only in highly invasive cells. Among them,IL-32was most strongly upregulated in the highly invasive cells, compared with cells with a low invasive potential, as well as the original cells. RT-qPCR and western blot analysis confirmed the high levels of expression of IL-32 in highly invasive cells at the RNA and protein levels. In addition, immunohistochemical analysis of resected surgical materials revealed that the tumor cells expressed IL-32 and, in particular, many IL-32 positive cells were seen at the invasive front of the tumor tissue. IL-32 is a cytokine that is widely involved in the development of cancer and has recently received considerable attention. This cytokine has multiple splice variants and shows a wide variety of behaviors, depending on the tumor type and primary organ. Although some hypotheses have been proposed to explain the activity of IL-32, a unified view has not been agreed. In the present study, through the establishment of highly invasive cells from pancreatic cancer and a comprehensive gene analysis, it is suggested that IL-32 may serve an important role as a molecule involved in the invasiveness of this neoplasm.
引用
收藏
页码:2888 / 2896
页数:9
相关论文
共 50 条
  • [31] Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL-32/PRTN3 expression
    Lei, Jing
    Xu, Feng
    Deng, Chao
    Nie, Xubiao
    Zhong, Li
    Wu, Zhixuan
    Li, Juan
    Wu, Xiaoling
    He, Song
    Chen, Yongyu
    [J]. CANCER SCIENCE, 2023, 114 (06) : 2414 - 2428
  • [32] IL-32θ downregulates CCL5 expression through its interaction with PKCδ and STAT3
    Bak, Yesol
    Kang, Jeong-Woo
    Kim, Man Sub
    Park, Yun Sun
    Kwon, Taeho
    Kim, Soohyun
    Hong, Jintae
    Yoon, Do-Young
    [J]. CELLULAR SIGNALLING, 2014, 26 (12) : 3007 - 3015
  • [33] Cancer-Associated Fibroblast-Secreted Exosomes Promote Gastric Cancer Cell Migration and Invasion via the IL-32/ESR1 Axis
    Shang, Lifeng
    Chen, Xinli
    Zhu, Tianyu
    Chong, Shujing
    Liu, Haiwang
    Huang, Wei
    Fu, Weibo
    She, Hao
    Shen, Xin
    [J]. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2024, 196 (09) : 6045 - 6058
  • [34] Integrated analysis of gene expression and methylation profiles of novel pancreatic cancer cell lines with highly metastatic activity
    Yang, Gang
    Wang, Huanyu
    Feng, Mengyu
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Cong, Lin
    Zhao, Yupei
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2019, 62 (06) : 791 - 806
  • [35] Multiple myeloma cell-derived IL-32γ increases the immunosuppressive function of macrophages by promoting indoleamine 2,3-dioxygenase (IDO) expression
    Yan, Haimeng
    Dong, Mengmeng
    Liu, Xinling
    Shen, Qiang
    He, Donghua
    Huang, Xi
    Zhang, Enfan
    Lin, Xuanru
    Chen, Qingxiao
    Guo, Xing
    Chen, Jing
    Zheng, Gaofeng
    Wang, Gang
    He, Jingsong
    Yi, Qing
    Cai, Zhen
    [J]. CANCER LETTERS, 2019, 446 : 38 - 48
  • [36] Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines
    Zhong, Zhiwei
    Zhou, Fan
    Wang, Dong
    Wu, Mingming
    Zhou, Weimin
    Zou, Yeqing
    Li, Jie
    Wu, Linquan
    Yin, Xiangbao
    [J]. ONCOLOGY REPORTS, 2018, 40 (06) : 3852 - 3860
  • [37] TIMP-1 expression induced by IL-32 is mediated through activation of AP-1 signal pathway
    Xu, Haixia
    Zhang, Shaoquan
    Pan, Xingfei
    Cao, Hong
    Huang, Xiaoping
    Xu, Qihuan
    Zhong, Haizhen
    Peng, Xiaomou
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 38 : 233 - 237
  • [38] IL-32α down-regulates β2 integrin (CD18) expression by suppressing PU.1 expression in myeloid cells
    Kang, Jeong-Woo
    Park, Yun Sun
    Kim, Man Sub
    Lee, Dong Hun
    Bak, Yesol
    Ham, Sun Young
    Song, Yong-Seok
    Hong, Jin Tae
    Yoon, Do-Young
    [J]. CELLULAR SIGNALLING, 2014, 26 (07) : 1514 - 1522
  • [39] Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells
    Tan, Xiaodong
    Zhou, Lei
    Wang, Huaitao
    Yang, Yifan
    Sun, Yang
    Wang, Zhaoping
    Zhang, Xiaobo
    Gao, Feng
    Li, Hansi
    [J]. ONCOLOGY LETTERS, 2018, 16 (05) : 6026 - 6038
  • [40] CHARACTERIZATION OF CANCER CELL-DISSOCIATION FACTOR IN A HIGHLY INVASIVE PANCREATIC-CANCER CELL-LINE
    KURIZAKI, T
    EGAMI, H
    HIROTA, M
    AKAGI, J
    OHMACHI, H
    YAMAMOTO, SI
    OGAWA, M
    [J]. CANCER, 1995, 75 (06) : 1554 - 1561